Spots Global Cancer Trial Database for AMT-562 in Patients With Selected Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: AMT-562 in Patients With Selected Advanced Solid Tumors
Official Title: First-in-Human, Phase 1 Study of AMT-562 in Patients With Advanced Solid Tumors
Study ID: NCT06199908
Conditions
Interventions
Study Description
Brief Summary: This is a first-in-human, non-randomized, open-label, multicenter Phase 1 study of AMT-562 in patients with advanced solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Macquarie University Hospital, North Ryde, New South Wales, Australia
Cabrini Malvern Hospital, Malvern, Victoria, Australia
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
